These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24480460)

  • 1. Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks.
    Sun H; Wang Y; Wang Z; Meng J; Qi Z; Yang G
    Biochim Biophys Acta; 2014 May; 1843(5):934-44. PubMed ID: 24480460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin.
    Lv J; Qian Y; Ni X; Xu X; Dong X
    Tumour Biol; 2017 Mar; 39(3):1010428317694307. PubMed ID: 28347251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
    Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
    Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of irradiation-induced repair foci in mouse embryonic stem cells].
    Suvorova II; Pospelov VA
    Tsitologiia; 2014; 56(5):340-5. PubMed ID: 25696973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.
    Ertych N; Stolz A; Valerius O; Braus GH; Bastians H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1817-22. PubMed ID: 26831064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer.
    Alsubhi N; Middleton F; Abdel-Fatah TM; Stephens P; Doherty R; Arora A; Moseley PM; Chan SY; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Martin SG; Curtin NJ; Madhusudan S
    Mol Oncol; 2016 Feb; 10(2):213-23. PubMed ID: 26459098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
    Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.
    Pan X; Mou J; Liu S; Sun Z; Meng R; Zhou Z; Wu G; Peng G
    Oncol Rep; 2015 Jun; 33(6):2999-3005. PubMed ID: 25962492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.
    Wang W; Guo M; Xia X; Zhang C; Zeng Y; Wu S
    Biomed Res Int; 2017; 2017():5718968. PubMed ID: 29082250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora-A: a potential DNA repair modulator.
    Wang Y; Sun H; Wang Z; Liu M; Qi Z; Meng J; Sun J; Yang G
    Tumour Biol; 2014 Apr; 35(4):2831-6. PubMed ID: 24277377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; SyljuÄsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
    Yang SH; Kuo TC; Wu H; Guo JC; Hsu C; Hsu CH; Tien YW; Yeh KH; Cheng AL; Kuo SH
    World J Gastroenterol; 2016 Aug; 22(32):7275-88. PubMed ID: 27621574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Chou WC; Hu LY; Hsiung CN; Shen CY
    Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
    Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
    J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
    Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
    Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.